Animalcare Group (ANCR) Competitors GBX 262 +10.00 (+3.97%) As of 08/22/2025 12:19 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock ANCR vs. AMYT, AGY, APH, VLG, STX, EAH, DNL, PXS, MXC, and RGTShould you be buying Animalcare Group stock or one of its competitors? The main competitors of Animalcare Group include Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Venture Life Group (VLG), Shield Therapeutics (STX), ECO Animal Health Group (EAH), Diurnal Group (DNL), Provexis (PXS), Argent BioPharma (MXC), and Argent BioPharma (RGT). These companies are all part of the "drug manufacturers - specialty & generic" industry. Animalcare Group vs. Its Competitors Amryt Pharma Allergy Therapeutics Alliance Pharma Venture Life Group Shield Therapeutics ECO Animal Health Group Diurnal Group Provexis Argent BioPharma Argent BioPharma Animalcare Group (LON:ANCR) and Amryt Pharma (LON:AMYT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment. Which has stronger valuation and earnings, ANCR or AMYT? Animalcare Group has higher earnings, but lower revenue than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£84.90M2.12£36.55M£53.644.88Amryt Pharma£210.24M0.00N/A-£33.00N/A Does the media refer more to ANCR or AMYT? In the previous week, Animalcare Group had 1 more articles in the media than Amryt Pharma. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Amryt Pharma. Animalcare Group's average media sentiment score of 0.44 beat Amryt Pharma's score of 0.00 indicating that Animalcare Group is being referred to more favorably in the media. Company Overall Sentiment Animalcare Group Neutral Amryt Pharma Neutral Do insiders and institutionals believe in ANCR or AMYT? 49.0% of Animalcare Group shares are owned by institutional investors. 29.5% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is ANCR or AMYT more profitable? Animalcare Group has a net margin of 43.05% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 36.62% beat Amryt Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group43.05% 36.62% 2.97% Amryt Pharma N/A N/A N/A SummaryAnimalcare Group beats Amryt Pharma on 9 of the 10 factors compared between the two stocks. Get Animalcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANCR vs. The Competition Export to ExcelMetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£179.63M£2.26B£5.83B£3.22BDividend Yield2.05%2.92%4.40%5.04%P/E Ratio4.884.3631.30164.70Price / Sales2.12691.66455.25310,111.42Price / Cash26.0510.3738.0227.93Price / Book1.6211.959.535.91Net Income£36.55M£20.70B£3.26B£5.89B7 Day Performance-0.33%1.04%2.14%49.52%1 Month Performance-9.83%4.28%2.81%56.36%1 Year Performance-4.03%3.63%30.70%136.20% Animalcare Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANCRAnimalcare GroupN/AGBX 262+4.0%N/A-5.1%£179.63M£84.90M4.88220News CoverageAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 7.50-10.7%N/A+82.8%£368.63M£72.18M-7.23612News CoverageAPHAlliance Pharma2.1029 of 5 starsGBX 64.70flatGBX 6,250+9,560.0%N/A£350.32M£183.50M-10.4391,000VLGVenture Life GroupN/AGBX 59-0.8%N/A+25.9%£75.18M£51.77M100.12165News CoverageSTXShield TherapeuticsN/AGBX 5.61+1.2%N/A+143.4%£55.40M£20.92M-1.4540,000News CoverageGap DownEAHECO Animal Health Group3.7191 of 5 starsGBX 73.41-0.1%GBX 150+104.3%-31.3%£49.74M£89.44M47.45234News CoveragePositive NewsDNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133PXSProvexisN/AGBX 0.78+5.7%N/A+9.0%£18.30M£846.98K-29.574Gap UpMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255News CoverageGap UpRGTArgent BioPharmaN/AN/AN/AN/A£8.31MN/A-0.65N/AGap DownHigh Trading Volume Related Companies and Tools Related Companies Amryt Pharma Alternatives Allergy Therapeutics Alternatives Alliance Pharma Alternatives Venture Life Group Alternatives Shield Therapeutics Alternatives ECO Animal Health Group Alternatives Diurnal Group Alternatives Provexis Alternatives Argent BioPharma Alternatives Argent BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ANCR) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Animalcare Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Animalcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access